A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.

Recruiting

• Conditions: Bladder Cancer; Kidney Cancer; Prostate Cancer

• Registration Number: NCT02186925
• Lead Sponsor: Meir Medical Center

Brief Summary

Identifying clinical factors such as medication, background diseases and blood tests that effect the course of disease in cancer patients can help physicians to better decide on the patient's treatment plan. The study seeks to identify and analyze relevant clinical factors that effect the course of the disease and the results of treatment in patients with cancers of the prostate, bladder and kidney.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Status Verified: 2014-07
• Study First Submitted: 2014-07-02
• Study First Submitted QC: 2014-07-07
• Study First Posted: 2014-07-10
• Study Start: 2014-08
• Last Update Submitted: 2015-04-20
• Last Update Posted: 2015-04-21
• Primary Completion: 2019-08
• Study Completion: 2025-08

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• All patients with prostate, bladder or kidney cancer that are being treated at the Meir Medical Center and are over 18 years of age.

Read More

Exclusion Criteria

• Patients under the age of 18

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Progression Free Survival	5 years	Univariate analysis will be used to assess the effects of clinical factors on progression free survival.

Secondary Outcome Measures

Name	Time	Method
Patient overall survival	5 years	Univariate analysis will be used to assess the effects of clinical factors on overall survival.

Trial Locations

Locations (1)

Meir Medical Center; 🇮🇱 Kvar Saba, Israel